September 2022 CDMO Opportunities And Threats Report
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...
Source: lifescienceleader.com
Page 5 - Pharma Intelligence Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharma Intelligence Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharma Intelligence Center Today - Breaking & Trending Today
Urticaria Marketed and Pipeline Drugs Assessment, Clinical
Summary This reports provides a data-driven overview of the current and future competitive landscape in Urticaria therapeutics. Synopsis...
Source: globenewswire.com
Global Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials an
DUBLIN--(BUSINESS WIRE)--The "Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the current and future competitive landscape in Waldenstrom Ma...
Source: pharmiweb.com
Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs
Summary This reports provides a data-driven overview of the current and future competitive landscape in Aicardi-Goutieres Syndrome therapeutics. Synopsis...
Source: globenewswire.com
OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of OLX10212 in Phase 1 Clinical Trial | DNA RNA and Cells
OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of OLX10212 in Phase 1 Clinical Trial
Source: pipelinereview.com